Aura Biosciences, Inc. (AURA) Scorecard
- 2026-Q2: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
5/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q20/3 |
LoseAURA / S&P 6.13% / 15.20% |
LoseAURA / S&P AURA unavailable / 15.00% |
LoseAURA / S&P -10.71% / 50.40% |
| 2026-Q11/3 |
WinAURA / S&P 22.75% / -4.33% |
LoseAURA / S&P AURA unavailable / 11.30% |
LoseAURA / S&P -8.42% / 27.70% |
| 2025-Q40/3 |
LoseAURA / S&P -11.81% / 2.65% |
LoseAURA / S&P AURA unavailable / 9.00% |
LoseAURA / S&P 2.29% / 13.40% |
| 2025-Q30/3 |
LoseAURA / S&P -1.28% / 8.12% |
LoseAURA / S&P AURA unavailable / 4.61% |
LoseAURA / S&P 12.14% / 13.45% |
| 2025-Q20/3 |
LoseAURA / S&P 6.83% / 10.94% |
LoseAURA / S&P AURA unavailable / 4.83% |
LoseAURA / S&P 9.50% / 10.63% |
| 2025-Q10/3 |
LoseAURA / S&P -28.71% / -4.27% |
LoseAURA / S&P AURA unavailable / 4.98% |
LoseAURA / S&P 2.15% / 10.57% |
| 2024-Q40/3 |
LoseAURA / S&P -7.74% / 2.41% |
LoseAURA / S&P AURA unavailable / 5.25% |
LoseAURA / S&P -8.85% / 6.15% |
| 2024-Q31/3 |
WinAURA / S&P 17.86% / 5.89% |
LoseAURA / S&P AURA unavailable / 5.89% |
LoseAURA / S&P -10.82% / 6.11% |
| 2024-Q20/3 |
LoseAURA / S&P -3.69% / 4.28% |
LoseAURA / S&P AURA unavailable / 5.38% |
LoseAURA / S&P -10.50% / 5.12% |
| 2024-Q10/3 |
LoseAURA / S&P -11.40% / 10.56% |
LoseAURA / S&P AURA unavailable / 5.71% |
LoseAURA / S&P -6.06% / 5.59% |
| 2023-Q40/3 |
LoseAURA / S&P -1.23% / 11.69% |
LoseAURA / S&P AURA unavailable / 6.81% |
LoseAURA / S&P -2.04% / 7.78% |
| 2023-Q30/3 |
LoseAURA / S&P -27.37% / -3.27% |
LoseAURA / S&P AURA unavailable / 7.52% |
LoseAURA / S&P -102.87% / -5.03% |
| 2023-Q21/3 |
WinAURA / S&P 33.08% / 8.74% |
LoseAURA / S&P AURA unavailable / 9.50% |
LoseAURA / S&P -105.03% / -8.57% |
| 2023-Q10/3 |
LoseAURA / S&P -11.62% / 7.50% |
LoseAURA / S&P AURA unavailable / 10.77% |
LoseAURA / S&P -116.95% / -15.69% |
| 2022-Q40/3 |
LoseAURA / S&P -42.05% / 7.56% |
LoseAURA / S&P AURA unavailable / 11.88% |
LoseAURA / S&P AURA unavailable / -17.99% |
| 2022-Q31/3 |
WinAURA / S&P 27.88% / -4.88% |
LoseAURA / S&P AURA unavailable / 13.47% |
LoseAURA / S&P AURA unavailable / -1.41% |
| 2022-Q20/3 |
LoseAURA / S&P -35.59% / -16.10% |
LoseAURA / S&P AURA unavailable / 13.71% |
LoseAURA / S&P AURA unavailable / 11.04% |
| 2022-Q11/3 |
WinAURA / S&P 29.56% / -4.60% |
LoseAURA / S&P AURA unavailable / 15.97% |
LoseAURA / S&P AURA unavailable / 42.23% |
| 2021-Q40/3 |
LoseAURA / S&P AURA unavailable / 11.03% |
LoseAURA / S&P AURA unavailable / 15.00% |
LoseAURA / S&P AURA unavailable / 96.40% |
| 2021-Q30/3 |
LoseAURA / S&P AURA unavailable / 0.58% |
LoseAURA / S&P AURA unavailable / 10.77% |
LoseAURA / S&P AURA unavailable / 69.42% |
| 2021-Q20/3 |
LoseAURA / S&P AURA unavailable / 8.55% |
LoseAURA / S&P AURA unavailable / 6.58% |
LoseAURA / S&P AURA unavailable / 51.81% |
| 2021-Q10/3 |
LoseAURA / S&P AURA unavailable / 6.17% |
LoseAURA / S&P AURA unavailable / -1.06% |
LoseAURA / S&P AURA unavailable / 7.39% |
| 2020-Q40/3 |
LoseAURA / S&P AURA unavailable / 12.15% |
LoseAURA / S&P AURA unavailable / -3.72% |
LoseAURA / S&P AURA unavailable / -33.42% |
| 2020-Q30/3 |
LoseAURA / S&P AURA unavailable / 8.93% |
LoseAURA / S&P AURA unavailable / -2.04% |
LoseAURA / S&P AURA unavailable / -27.10% |
| 2020-Q20/3 |
LoseAURA / S&P AURA unavailable / 20.54% |
LoseAURA / S&P AURA unavailable / -0.46% |
LoseAURA / S&P AURA unavailable / -27.11% |
| 2020-Q10/3 |
LoseAURA / S&P AURA unavailable / -19.60% |
LoseAURA / S&P AURA unavailable / 3.47% |
LoseAURA / S&P AURA unavailable / -14.75% |
| 2019-Q40/3 |
LoseAURA / S&P AURA unavailable / 9.07% |
LoseAURA / S&P AURA unavailable / 5.36% |
LoseAURA / S&P AURA unavailable / 2.99% |
| 2019-Q30/3 |
LoseAURA / S&P AURA unavailable / 1.70% |
LoseAURA / S&P AURA unavailable / 5.02% |
LoseAURA / S&P AURA unavailable / 0.21% |
| 2019-Q20/3 |
LoseAURA / S&P AURA unavailable / 4.30% |
LoseAURA / S&P AURA unavailable / 6.64% |
LoseAURA / S&P AURA unavailable / 8.65% |
| 2019-Q10/3 |
LoseAURA / S&P AURA unavailable / 13.65% |
LoseAURA / S&P AURA unavailable / 8.12% |
LoseAURA / S&P AURA unavailable / 14.29% |
| 2018-Q40/3 |
LoseAURA / S&P AURA unavailable / -13.52% |
LoseAURA / S&P AURA unavailable / 9.05% |
LoseAURA / S&P AURA unavailable / 18.23% |
| 2018-Q30/3 |
LoseAURA / S&P AURA unavailable / 7.71% |
LoseAURA / S&P AURA unavailable / 10.21% |
LoseAURA / S&P AURA unavailable / 19.06% |
| 2018-Q20/3 |
LoseAURA / S&P AURA unavailable / 3.43% |
LoseAURA / S&P AURA unavailable / 9.03% |
LoseAURA / S&P AURA unavailable / 14.46% |
| 2018-Q10/3 |
LoseAURA / S&P AURA unavailable / -0.76% |
LoseAURA / S&P AURA unavailable / 7.68% |
LoseAURA / S&P AURA unavailable / 12.46% |
| 2017-Q40/3 |
LoseAURA / S&P AURA unavailable / 6.64% |
LoseAURA / S&P AURA unavailable / 7.03% |
LoseAURA / S&P AURA unavailable / 13.82% |
| 2017-Q30/3 |
LoseAURA / S&P AURA unavailable / 4.48% |
LoseAURA / S&P AURA unavailable / 5.68% |
LoseAURA / S&P AURA unavailable / 17.57% |
| 2017-Q20/3 |
LoseAURA / S&P AURA unavailable / 3.09% |
LoseAURA / S&P AURA unavailable / 4.83% |
LoseAURA / S&P AURA unavailable / 17.74% |
| 2017-Q10/3 |
LoseAURA / S&P AURA unavailable / 6.07% |
LoseAURA / S&P AURA unavailable / 3.67% |
LoseAURA / S&P AURA unavailable / 13.32% |
| 2016-Q40/3 |
LoseAURA / S&P AURA unavailable / 3.82% |
LoseAURA / S&P AURA unavailable / 2.09% |
LoseAURA / S&P AURA unavailable / 7.05% |
| 2016-Q30/3 |
LoseAURA / S&P AURA unavailable / 3.85% |
LoseAURA / S&P AURA unavailable / 0.20% |
LoseAURA / S&P AURA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | AURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 23.00% | 20.78% |
| Annualized return | 23.00% | 20.78% |
5Y · 2021-10-29 to 2026-08-27
| Metric | AURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.97% | 83.14% |
| Annualized return | -12.25% | 12.86% |
10Y · 2021-10-29 to 2026-08-27
| Metric | AURA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -47.97% | 319.30% |
| Annualized return | -6.33% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |